Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer's and Parkinson's Disease
Neurodegenerative disorders entail a progressive loss of neurons in cerebral and peripheral tissues, coupled with the aggregation of proteins exhibiting altered physicochemical properties. Crucial to these conditions is the gradual degradation of the central nervous system, manifesting as impairment...
Saved in:
Main Authors: | Antea Krsek (Author), Lara Baticic (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innovative Therapeutic Strategies in Alzheimer's Disease: A Synergistic Approach to Neurodegenerative Disorders
by: Sarfaraz K. Niazi, et al.
Published: (2024) -
Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective
by: Mohammed Alrouji, et al.
Published: (2024) -
The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer's Disease Therapeutics and Diagnostics
by: Cristina de la Torre, et al.
Published: (2018) -
Nanotechnology platforms in Parkinson's Disease
by: Rishi Rajat Adhikary, et al.
Published: (2015) -
Genotype-driven therapeutic developments in Parkinson's disease
by: Jannik Prasuhn, et al.
Published: (2021)